Back to All Events

EASD STOCKHOLM 2022


Speeches by researchers from Oslo Diabetes Research Centre

Final programme, covering all speeches, see: EASD Programme

OP 22 Giving birth with diabetes  14:30 - 16:00 Nobel Hall Chair: J. Puder, Switzerland    

132 Beta cell function, hepatic insulin clearance and insulin sensitivity in South Asian and Nordic women after gestational diabetes. A. Sharma, I. Nermoen, E. Qvigstad, C. Sommer, N. Sattar, J. Gill, H. Gulseth, S. Sollid, K. Birkeland, S. Lee-Ødegård, Norway, UK          (p. 73)

 

OP 41 Viruses and diabetes: more than COVID-19   09:45 - 10:45  Doniach Hall Chair: K. Khunti, UK

233 SARS-CoV-2 infection and subsequent risk of type 1 diabetes in 1.2 million children. H.L. Gulseth, P.L. Ruiz, K. Størdal, Ø. Karlstad, N. Gunnes, N.A. Lund-Blix, H. Bøås, L.C. Stene, G. Tapia, Norway              (p. 121)

 

Short Oral Discussions Event C Wednesday, 12:00 - 13:00 Chair: E. Bezerra Parente, Finland                  

SO 63 Diversity of the diabetic kidney 742 Chronic kidney disease in a contemporary nationwide register of patients with and without type 2 diabetes. T.G. Jenssen, K. Sveen, J. Bodegård, M. Thuresson, K.I. Birkeland, Norway, Sweden (p. 198)

 

Short Oral Discussions Event E Thursday, 12:00 - 13:00 Chair: N. Rajamand Ekberg, Sweden

SO 11 Novel biomarkers and risk factors 340 Role of soluble leptin receptor in diabetes prevention? Combination of cross-sectional, clinical intervention and Mendelian randomisation studies. C. Sommer, K.G. Vangberg, G.-H. Moen, D.M. Evans, S. Lee-Ødegård, I.K. Blom-Høgestøl, L. Sletner, A.K. Jenum, C.A. Drevon, H.L. Gulseth, K.I. Birkeland, Norway, Australia (p. 144)

 

Short Oral Discussions Event E Thursday, 12:00 - 13:00 Chair: K.E. Berntorp, Sweden   SO 23 Gestational diabetes and pregnancy                                                 436 Insulin sensitivity, growth differentiation factor-15 and fetuin-B during pregnancy after assisted reproductive therapy in the STORK cohort.  E. Qvigstad, M.-C.P. Roland, K. Godang, T. Lekva, Norway (p. 156)

 

Short Oral Discussions Event F, Thursday, 13:15 - 14:15 Chair: N. Lalic, Serbia   349 Risk factors for development of de novo post transplantation diabetes from 8 weeks after kidney transplantation R. Carlsen, A. Åsberg, M. Svensson, K.I. Birkeland, I. Bressendorff, H.L. Gulseth, K. Midtvedt, T.G. Jenssen, Norway, Denmark (p. 145)

 

Wednesday, 17.30-18.30 Peltonen Hall Chair: Sofia Carlsson, Sweden & Sanjoy Dutta, USA     EASD/JDRF Symposium: Prevention of type 1 diabetes, is it possible?

Speaker: Anette G Ziegler, Germany: New avenues in the prevention of type 1 diabetes

Lars C Stene, Norway: Genes vs environment in the development of type 1 diabetes

 

Short Oral Discussions Event D Wednesday, 13:15 - 14:15 SO 04 Starting with autoimmunity 287 Family history of type 1 diabetes is associated with incidence of multiple islet autoimmunity but not with progression to clinical type 1 diabetes: the MIDIA study. L. Stene, Norway

SO 76 853 The prognostic impact of HbA1c and diabetes on mortality in chronic heart failure. K. Sveen, M. Grundtvig, L. Gullestad, K.I. Birkeland, Norway